Policy Development and Program Planning Skills, Communication Skills, Health Equity Skills, Public Health Sciences Skills, Management and Finance Skills, Leadership and Systems Thinking Skills Brian Tolleson Policy Development and Program Planning Skills, Communication Skills, Health Equity Skills, Public Health Sciences Skills, Management and Finance Skills, Leadership and Systems Thinking Skills Brian Tolleson

PART 9.3

There are medicines that could save the lives of the 500,000 children who die from malaria each year. Most of these children live in the low-income countries of Sub-Saharan Africa. Novartis manufactures the drug, artemisinin-based combination therapy, that is the standard of care for the treatment of P. falciparum malaria, the most deadly form of the disease. Although the global health community has for a long time been skeptical and wary of the private sector where profit was the driving force, Novartis happened to have a CEO who came from the field of global health and was inspired by the vision of global health equity. But neither these malaria-endemic countries nor WHO could afford to purchase commercially the amounts of this drug needed to treat the children who were at risk.

Read More